New Ray Medicine International Holding Ltd
06108
Company Profile
Business description
New Ray Medicine International Holding Ltd is engaged in the trading and distribution of pharmaceutical products in the People's Republic of China. The company's segments include the Distribution and trading of pharmaceutical products and the Provision of marketing and promotion services. Distribution and trading of pharmaceutical products segment consist of Injection drugs and generate maximum revenue for the company.
Contact
19 Dangui Road
B-C, 37th Floor, Dikai International Center
Hangzhou
CHNSector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2025
Employees
30
Stocks News & Analysis
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
stocks
A 5-Star US stock to buy with a near-5% yield
Undervalued by 23%, this cheap dividend stock is a top pick in its sector.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,150.70 | 47.60 | 0.52% |
| CAC 40 | 7,870.68 | 75.26 | 0.97% |
| DAX 40 | 23,739.47 | 204.64 | 0.87% |
| Dow JONES (US) | 46,247.29 | 299.97 | 0.65% |
| FTSE 100 | 9,284.83 | 70.85 | 0.77% |
| HKSE | 26,393.92 | 265.72 | 1.02% |
| NASDAQ | 22,484.07 | 99.37 | 0.44% |
| Nikkei 225 | 44,926.34 | 428.65 | -0.95% |
| NZX 50 Index | 13,238.55 | 126.82 | 0.97% |
| S&P 500 | 6,643.70 | 38.98 | 0.59% |
| S&P/ASX 200 | 8,864.30 | 53.60 | 0.61% |
| SSE Composite Index | 3,814.83 | 13.28 | -0.35% |